➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
McKinsey
AstraZeneca
Mallinckrodt
Moodys

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Plitidepsin

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Plitidepsin?

Plitidepsin is an investigational drug.

There have been 12 clinical trials for Plitidepsin. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2010.

The most common disease conditions in clinical trials are Neoplasms, Plasma Cell, Multiple Myeloma, and Lymphoma. The leading clinical trial sponsors are PharmaMar, Apices Soluciones S.L., and Institut Bergonié.

Recent Clinical Trials for Plitidepsin
TitleSponsorPhase
Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19Apices Soluciones S.L.Phase 1
Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19PharmaMarPhase 1
Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and LenalidomidePharmaMarPhase 2

See all Plitidepsin clinical trials

Clinical Trial Summary for Plitidepsin

Top disease conditions for Plitidepsin
Top clinical trial sponsors for Plitidepsin

See all Plitidepsin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
McKinsey
AstraZeneca
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.